Description

Description

Atem 0.025% Nebuliser Solution is a bronchodilator solution manufactured by Chiesi Pharmaceuticals, an internationally recognized pharmaceutical company with a strong focus on respiratory care. It contains Ipratropium Bromide, a medicine used to relieve and prevent shortness of breath in patients with chronic obstructive pulmonary disease, chronic bronchitis, and mild-to-moderate asthma. Unlike tablets or capsules, this solution is designed to be converted into a fine mist using a nebulizer machine, allowing the medicine to be inhaled directly into the lungs for fast and targeted relief. This method of delivery is especially helpful for patients experiencing significant breathing difficulty, as it allows the medicine to act directly on the airways rather than passing through the digestive system first. The pack contains 10 single-use ampoules, each intended for one nebulization session as directed by a physician.

Ingredients

Each 2ml ampoule of Atem 0.025% Nebuliser Solution contains Ipratropium Bromide Monohydrate as the sole active pharmaceutical ingredient, equivalent to Ipratropium Bromide at a concentration of 0.025 percent. Ipratropium Bromide belongs to a class of medicines known as anticholinergic bronchodilators, and it works by blocking the action of acetylcholine, a natural chemical messenger in the body that can trigger the muscles surrounding the airways to tighten and narrow. By blocking this effect, the ingredient helps the airway muscles relax and widen, making it easier for air to move in and out of the lungs. The solution itself is a clear, colorless, sterile liquid formulated specifically for use with a nebulizer device rather than for oral or injectable use.

Dosage Form

Atem 0.025% Nebuliser Solution is supplied as a sterile solution for inhalation via nebulizer, packaged in individual 2ml single-dose ampoules, often referred to as unit dose vials. The full pack contains 10 ampoules in total, with each one intended for a single treatment session and not meant to be reused or stored once opened. This form allows for precise, consistent dosing with each use, since each ampoule contains a fixed, premeasured amount of the medicine.

Uses

Atem 0.025% Nebuliser Solution is primarily used for the prevention and treatment of shortness of breath in patients with chronic obstructive pulmonary disease, chronic bronchitis, and mild-to-moderate bronchial asthma, particularly in cases involving an asthmatic component. By relaxing the muscles surrounding the airways, this medicine helps ease symptoms such as wheezing, chest tightness, and difficulty breathing, allowing for more comfortable and effective airflow. It is often used as part of a broader respiratory treatment plan, sometimes alongside other bronchodilators or inhaled medicines, to provide more comprehensive symptom control. This solution is generally intended for patients who require nebulized therapy rather than a standard inhaler, such as those experiencing more significant breathing difficulty or those who find inhaler technique challenging.

How To Use

Atem 0.025% Nebuliser Solution should only be used exactly as directed by a physician, with the specific dose depending on the patient’s age, condition, and the severity of their symptoms. To use it, the contents of one ampoule are typically emptied into the nebulizer’s medication chamber, and the device is then used to convert the solution into a fine mist that is inhaled through a mouthpiece or face mask. The patient should sit upright and breathe calmly and steadily until the chamber is empty, with each treatment session usually taking between five and fifteen minutes. Care should be taken to avoid getting the solution in the eyes during use, and if this happens, the eyes should be rinsed thoroughly with water. The nebulizer should be cleaned according to the manufacturer’s instructions after each use to help prevent infection. Only one ampoule should be used per session, and any unused portion of an opened ampoule should be discarded rather than saved for later use.

Side Effects

Atem 0.025% Nebuliser Solution may cause side effects in some patients, though many tolerate it well. Commonly reported effects include headache, dizziness, throat irritation, cough, dry mouth, and nausea. Some patients may also experience constipation or difficulty fully emptying the bladder. Less commonly, this medicine may cause a temporary worsening of breathing difficulty immediately after use, known as paradoxical bronchospasm, as well as a faster heartbeat or irregular heart rhythm. Any sudden worsening of breathing after using this medicine should be treated as an emergency, and the nebulizer treatment should be stopped while medical help is sought. Patients with a known hypersensitivity to Ipratropium Bromide or to atropine-related substances should not use this medicine. Any unusual or severe symptoms should be reported to a doctor promptly.

Pregnancy & Breastfeeding

The effects of Atem 0.025% Nebuliser Solution during pregnancy are not well established, so it should only be used if a doctor determines that it is clearly needed, after considering the potential benefits against any possible risks. Women who are pregnant, believe they may be pregnant, or are planning to conceive should discuss their respiratory treatment plan with their doctor. Similarly, the effects of this medicine during breastfeeding are not well established, so breastfeeding mothers should consult their doctor before using it to determine whether it is appropriate for their situation.

Storage Instructions

Atem 0.025% Nebuliser Solution should be stored at a temperature not exceeding 25°C, away from direct sunlight, heat, and moisture. The ampoules should be kept sealed within their original foil pouch or packaging until they are ready to be used, and the medicine should never be frozen. Ampoules should always be kept out of the reach and sight of children, and any unused solution remaining in an opened ampoule should not be stored for later use. This medicine should not be used once the expiry date printed on the packaging has passed.

FAQS

Q: Can this solution be taken by mouth instead of using a nebulizer?
No, this solution is intended strictly for inhalation via a nebulizer device and should never be swallowed or taken by any other route.

Q: Can more than one ampoule be used in a single treatment session?
The dose should only be determined by a physician based on the patient’s age, condition, and severity of symptoms, and should never be adjusted independently.

Q: What should be done if breathing suddenly worsens after using this medicine?
This should be treated as a medical emergency; the treatment should be stopped and medical help should be sought immediately, as this may indicate a rare reaction known as paradoxical bronchospasm.

Q: Can an opened ampoule be saved and used again later?
No, each ampoule is intended for single use only, and any unused solution remaining after a treatment session should be discarded.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.